Showing results (2061-2070 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|May 7, 2013
Design, synthesis, and biological evaluation of pyridoquinazoline derivatives as potent epidermal growth factor receptor inhibitorsSarika Rani, Lata Sridhar, Rakesh Srivastava, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 12, 2013
Characteristic variation of α-fetoprotein DNA nanometer-range irradiated by iodine-125Mu-hua Cheng, Yao-xiong Huang, Jian-fang Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
Advantages of proton therapy in non-small cell lung cancersChenfang Fan, Yong Li, Qian Liu
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumorsMohamed Altai, Zohreh Varasteh, Karl Andersson, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 12, 2012
In vivo distribution of (131)I and (125)I dual-labeled gelatin microspheres after implantation into rabbit liverYu Ma, Bo Li, Lin Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 28, 2012
Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitroSumei Chen, GuangSu Xiong, Shuming Wu, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2012
Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cellsBiao Zhong, Hongyan Shen, Xin Sun, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 17, 2014
Thulium-170-labeled microparticles for local radiotherapy: preliminary studiesAndras Polyak, Tapas Das, Sudipta Chakraborty, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 17, 2014
Camptothecin Enhances Cell Death Induced by (177)Lu-EDTMP in Osteosarcoma CellsChandan Kumar, Kusum Vats, Sharad P Lohar, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 17, 2014
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled PeptideCatharina M van Rij, Cathelijne Frielink, David M Goldenberg, et al.
Pageof 224